Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001013594-26-000264·MADRIGAL PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Madrigal Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 558868105
Event date: 2025-12-31
- Filing-level shares
- 1,707,522
- Percent of class
- 7.5%
- PAULSON & CO. INC.
Shares: 1,707,522 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001013594-26-000264
- Form type
- SCHEDULE 13G/A
- Filer
- MADRIGAL PHARMACEUTICALS, INC.
- CIK
- CIK 1157601
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership